WHO vaccine-preventable diseases: monitoring system. 2015 global summary

Last updated 15-Jul-2015 (Data received as of 10-Jul-2015)
Next overall update Fall 2015
EPI mother and child logo         
Select a country

Development status: Economy in transition GNI / capita (US$): 4'4601 Infant (under 12 months) mortality rate: 152
GDP / capita (US$): 10'4281 Child (under 5 years) mortality rate: 172

Population data in thousands3

  2014  2013  2012  2011  2010  2000  1990  1980 
Total population 3'185  3'173  3'162  3'154  3'150  3'305  3'447  2'735 
Births 41  41  40  40  40  62  85  80 
Surviving infants 41  40  40  39  39  61  82  77 
Pop. less than 5 years 199  198  198  198  197  321  415  375 
Pop. less than 15 years 637  655  675  696  719  1'003  1'173  1'044 
Female 15-49 years 818  815  811  807  805  866  864  640 

Number of reported case

(Click for retrospective incidence data for Albania)
Diphtheria 17 
Japanese encephalitis
Measles 28  10  662 
Mumps 20  18  39  21  1'651 
Pertussis 16  89  329  137 
Polio*
Rubella 1'752 
Rubella (CRS)
Tetanus (neonatal)
Tetanus (total)** 15 
Yellow fever
* Polio refers to all polio cases (indigenous or imported), including polio cases caused by vaccine derived polio viruses (VDPV). For desagregated data please click on this hyperlink: https://extranet.who.int/polis/public/CaseCount.aspx
it does not include cases of vaccine-associated paralytic polio (VAPP) and cases of non polio acute flaccid paralysis [AFP]).
** Neonatal Tetanus and Total Tetanus cases equality may be the result from a lack of non-Neonatal Tetanus surveillance system.

Percentage target population vaccinated by antigen

Hovering over an antigen reveals its fuller definition
  Most recent coverage survey4  

Official country estimates5

  (Click for retrospective coverage estimates data for Albania)
Vaccine year result method % card seen                                                
BCG 2008  98  DHS   96  99*  99*  96  97  99*  93  94 
DTP1 2008  100  DHS   96  99  99  99  99  99  98 
DTP3 2008  98  DHS   96  99  99  99  99  99  97  94 
DTP4          98  99 
IPV1          99 
HepB_BD          99  99*  97  99  99*  98 
HepB3 2008  98  DHS   96  99  99  99  99  99  96 
Hib3          99  99  99  99  99 
JapEnc         
MCV1          98  99  98  99  99  95 
MCV2          98  99  99  99  99 
PCV1          99  99  99  99 
PCV3          99  99  99  99 
Pol3 2008  98  DHS   96  98  99  99  99  99  97 
Rota1         
Rota_last         
Rubella1          98  99  98  99  99 
TT2plus          75  85  89 
PAB         
VAD1         
YFV         
  ° indicates that more than 1 survey occurred that year

  Next update: Mid July 2016

WHO-UNICEF estimates6

  (Click for full retrospective WHO-UNICEF coverage estimates data for Albania)
BCG 99  99  96  97  99  93  94  93 
DTP1 99  99  99  99  99  98  97  97 
DTP3 98  99  99  99  99  97  94  94 
HepB3 98  99  99  99  99  96 
HepB_BD 99  99  97  97  99  98 
Hib3 98  99  99  99  99 
MCV1 98  99  98  99  99  95  88  90 
MCV2 98  99  99  99  98 
PAB 92  87  87  87  87  86  30 
PCV3 99  99  99  99 
Pol3 98  99  99  99  99  97  89  92 
Rota_last

Number of districts in the country 36  Proportion of
districts reporting
DTP3 coverage:
% of coverage reports received at national
level vs number of reports expected
100 
   
/
|
|
\
Greater or equal to 90% 97
From 80 to 89% 3
From 50 to 79% 0
Less than 50% 0
Proportion of districts
not reporting DTP3 coverage
0
 

Immunization Schedule (2014 or latest available)

Hovering over an antigen reveals its fuller definition
Vaccine Schedule Entire country Comment
BCG birth; Yes
DT 6 years; Yes
DTwP 2 years; Yes
DTwPHibHepB 2, 4, 6 months; Yes
HepB_Pediatric birth; Yes
IPV 2, 4 months; Yes
MMR 1, 5 years; Yes
OPV 6 months; 2, 6 years; Yes
Pneumo_conj 2, 4, 6 months; Yes
Rotavirus Yes From March 2016
Td 14 years; Yes

Immunizaton indicators

Indicator Expected answer 2014  2013  2012  2011  2010  2009  2008 

Planning and management

Has the country a Multi-Year Plan (MYP) for immunization? Yes/No/NR Yes  Yes  Yes  Yes  Yes  Yes  Yes 
What years does the MYP cover? number 2009-2013  2009-2013  2009-2013  2009-2013  2009 -2013  2009 -2013  2009 -2013 
Nº of districts with microplans that include activities to raise immunization coverage number 36  36  36 

System performance

Total Nº districts in country number 36  36  36  36  36  36  36 
Nº districts with DTP3 coverage >=80% number 36  36  36  36  36  36  36 
% of districts with DTP3 coverage >=80% From 0 to 100% 100  100  100  100  100  100  100 
Nº districts with measles (MCV1) coverage >=95% number 34  36  35  35  36  28  34 
% of districts with MCV1 coverage >=95% From 0 to 100% 94  100  97  97  100  78  94 

Safety

Has the country a vaccine adverse events review committee? Yes/No/NR/ND Yes  Yes  Yes  Yes  Yes     
Is there a national system to monitor adverse events following immunization (AEFI)? Yes/No/NR Yes  Yes  Yes  Yes  Yes  Yes  Yes 

Finance

Immunization expenditure financed, using Government funds? From 0 to 100%   3-5  3-5  100  100 

National Immunization Advisory Mechanism

Has the country a standing technical advisory group on immunization (NITAG)? Yes/No/NR Yes  Yes  Yes  Yes  Yes     

Sources

 1  "The 2015 World Bank Development Indicators Online", GDP per capita is PPP adjusted.
 2  World Health Statistics 2013, data for 2012
 3  "United Nations, Population Division. The World Population Prospects - the 2012 revision". New York, 2013.
 4  UNICEF/WHO survey database
 5  If no official estimate is available, the administrative coverage is reported. '*' indicates coverage over 99.5%.
 6  WHO-UNICEF estimates.